Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05154487
Title A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors GOG Foundation
Indications

endometrial carcinoma

Therapies

Alpelisib + Fulvestrant

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST